Literature DB >> 29724289

Methods to control anticancer chemotherapy preparations ranked by risk analysis.

M Savelli, M Roche, C Curti, C Bornet, P Rathelot, M Montana, P Vanelle.   

Abstract

The observed increase in cancer led to a continuous rise in anticancer drug preparations in Hospital Centres. The quality and security of these preparations are essential to ensure the efficacy and to limit the risk of iatrogenic toxicity. Several methods have been described to secure the process of preparation (i.e. non-analytical methods for the control during the fabrication; analytical methods for the final product evaluation). These different methods have been presented in many studies, in particular in descriptive studies, but in practice, selecting a method is difficult and related to needs and hospital priorities. Therefore, we decided to conduct this present review focused on various existing methods allowing enhancement in security of anti-cancer drugs preparation process. A proactive hazard analysis method was applied, considering preparation and control steps, to discuss the choice of a method in terms of quality and security and to identify potential risks of failure. The results show that none method is perfect. Methods with the lowest criticality score are the robotization closely followed by Drugcam® in the case of re-labelling of all containers. According to these elements a University Hospital Centre could consider these risk indexesimplementing control methods.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29724289     DOI: 10.1691/ph.2018.7205

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  Chemometric Analysis of UV-Visible Spectral Fingerprints for the Discrimination and Quantification of Clinical Anthracycline Drug Preparation Used in Oncology.

Authors:  Aimen El Orche; Casimir Adade Adade; Hafid Mefetah; Amine Cheikh; Khalid Karrouchi; Miloud El Karbane; Mustapha Bouatia
Journal:  Biomed Res Int       Date:  2021-05-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.